Clinical Trial Update: EpiDetect Study: Clinical Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes Patients [NA]

View source ↗

Summary

The EpiDetect study, a clinical trial validating a pancreatic cancer detection test in patients with new-onset diabetes, has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: ClearNote Health | Conditions: Pancreatic Cancer | NA | Status: WITHDRAWN